155 related articles for article (PubMed ID: 2820806)
1. Effects of protein kinase C activation on human platelet cyclic AMP metabolism.
Bushfield M; Hopple SL; Gibson IF; Murdoch FA; MacIntyre DE
FEBS Lett; 1987 Oct; 222(2):299-304. PubMed ID: 2820806
[TBL] [Abstract][Full Text] [Related]
2. Effects of activation of protein kinase C on the agonist-induced stimulation and inhibition of cyclic AMP formation in intact human platelets.
Williams KA; Murphy W; Haslam RJ
Biochem J; 1987 May; 243(3):667-78. PubMed ID: 2444206
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the effects of phorbol 12-myristate 13-acetate and prostaglandin E1 on calcium regulation in human platelets.
Yoshida K; Stark F; Nachmias VT
Biochem J; 1988 Jan; 249(2):487-93. PubMed ID: 2829859
[TBL] [Abstract][Full Text] [Related]
4. The binding of 6-oxo-prostaglandin E1 to platelet prostanoid receptors.
Jaschonek K; Renn W; Weisenberger H
Prostaglandins Leukot Med; 1986 Sep; 24(1):79-86. PubMed ID: 3020591
[TBL] [Abstract][Full Text] [Related]
5. Effects of suramin on increases in cytosolic calcium and on inhibition of adenylate cyclase induced by adenosine 5'-diphosphate in human platelets.
Hall DA; Hourani SM
Biochem Pharmacol; 1994 Mar; 47(6):1013-8. PubMed ID: 8147900
[TBL] [Abstract][Full Text] [Related]
6. Cytoplasmic Ca2+ in platelets is controlled by cyclic AMP: antagonism between stimulators and inhibitors of adenylate cyclase.
Zavoico GB; Feinstein MB
Biochem Biophys Res Commun; 1984 Apr; 120(2):579-85. PubMed ID: 6329175
[TBL] [Abstract][Full Text] [Related]
7. Refractoriness of platelets to prostaglandins after infusion in rabbits.
Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
[TBL] [Abstract][Full Text] [Related]
8. Modulation of adenylate cyclase of human platelets by phorbol ester. Impairment of the hormone-sensitive inhibitory pathway.
Jakobs KH; Bauer S; Watanabe Y
Eur J Biochem; 1985 Sep; 151(2):425-30. PubMed ID: 4040856
[TBL] [Abstract][Full Text] [Related]
9. Selective inactivation by endogenous protein kinase C of human platelet high-affinity GTPase coupled with PAF receptors.
Avdonin PV; Svitina-Ulitina IV; Tkachuk VA
J Mol Cell Cardiol; 1989 Feb; 21 Suppl 1():139-43. PubMed ID: 2543823
[TBL] [Abstract][Full Text] [Related]
10. Novel mechanism of heterologous desensitization of adenylate cyclase: prostaglandins bind with different affinities to both stimulatory and inhibitory receptors on platelets.
Ashby B
Mol Pharmacol; 1990 Jul; 38(1):46-53. PubMed ID: 1695318
[TBL] [Abstract][Full Text] [Related]
11. Desensitization of prostaglandin-activated platelet adenylate cyclase.
Cooper B; Schafer AI; Puchalsky D; Handin RI
Prostaglandins; 1979 Apr; 17(4):561-71. PubMed ID: 461820
[TBL] [Abstract][Full Text] [Related]
12. Effects of TRK-100, a stable prostacyclin analogue, on regulation of cyclic AMP metabolism in platelets.
Nogimori K; Kajikawa N; Nishio S; Yajima M
Prostaglandins; 1989 Feb; 37(2):205-12. PubMed ID: 2543034
[TBL] [Abstract][Full Text] [Related]
13. Calcium-dependent proteolytic stimulation of adenylate cyclase in platelets from spontaneously hypertensive rats.
Tremblay J; Hamet P
Metabolism; 1984 Aug; 33(8):689-95. PubMed ID: 6087083
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
Haslam RJ; Davidson MM; Desjardins JV
Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
[TBL] [Abstract][Full Text] [Related]
15. Competitive antagonism at thromboxane receptors in human platelets.
Armstrong RA; Jones RL; Peesapati V; Will SG; Wilson NH
Br J Pharmacol; 1985 Mar; 84(3):595-607. PubMed ID: 2580580
[TBL] [Abstract][Full Text] [Related]
16. Prostacyclin increases cyclic AMP levels and adenylate cyclase activity in platelets.
Best LC; Martin TJ; Russell RG; Preston FE
Nature; 1977 Jun; 267(5614):850-2. PubMed ID: 197414
[No Abstract] [Full Text] [Related]
17. Involvement of protein kinase C in the UTP-mediated potentiation of cyclic AMP accumulation in mouse J774 macrophages.
Lin WW; Chen BC
Br J Pharmacol; 1997 Aug; 121(8):1749-57. PubMed ID: 9283713
[TBL] [Abstract][Full Text] [Related]
18. The thienopyridine ticlopidine selectively prevents the inhibitory effects of ADP but not of adrenaline on cAMP levels raised by stimulation of the adenylate cyclase of human platelets by PGE1.
Gachet C; Cazenave JP; Ohlmann P; Bouloux C; Defreyn G; Driot F; Maffrand JP
Biochem Pharmacol; 1990 Dec; 40(12):2683-7. PubMed ID: 2175608
[TBL] [Abstract][Full Text] [Related]
19. Roles of atypical protein kinase C in lysophosphatidic acid-induced type II adenylyl cyclase activation in RAW 264.7 macrophages.
Lin WW; Chang SH; Wang SM
Br J Pharmacol; 1999 Nov; 128(6):1189-98. PubMed ID: 10578131
[TBL] [Abstract][Full Text] [Related]
20. Distinct PKC isoforms mediate the activation of cPLA2 and adenylyl cyclase by phorbol ester in RAW264.7 macrophages.
Lin WW; Chen BC
Br J Pharmacol; 1998 Dec; 125(7):1601-9. PubMed ID: 9884090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]